Skip to content

Neuromuscular blocking/stimulation in cerebral palsy

Functional Outcomes of Botulinum Neurotoxin-A Injection Followed by Reciprocal Electrical Stimulation of Upper-Limb Muscles in Children with Cerebral Palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200215046504N1
Enrollment
56
Registered
2020-07-29
Start date
2018-08-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy. Cerebral palsy

Interventions

Intervention 1: Intervention group: 1) Children will receive a single set of intramuscular injection of botulinum toxin-A (Botox®, Allergan PLC, Dublin, Ireland). To increase injection tolerance, chil
Chattanooga, TS, USA) with a dual-channel stimulating unit will be used, each channel has two small-size, rectangular carbon rubber electrodes (3x5 cm), which will be enclosed in two spongy covers. Ch

Sponsors

Prince Sattam bin Abdulaziz University/Deanship of Scientific Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 10 Years

Inclusion criteria

Inclusion criteria: Diagnosis of spastic hemiplegic cerebral palsy age between 6 and 10 years Spasticity grade II or III according to Modified Ashworth Scale mental capacity enabling compliance with evaluation and treatment instructions Normal/corrected visual and auditory function

Exclusion criteria

Exclusion criteria: Contractures limiting arm-hand function Botulinum toxin-A injection in the involved upper limb in the past six months If children will be advised against stopping spasticity-relieving medications during the study period by their neuro-pediatrician Orthopedic or neuromuscular surgery or casting of the paretic upper limb within 1 year before starting study Uncontrolled seizures

Design outcomes

Primary

MeasureTime frame
Unilateral upper-limb function. Timepoint: Pre-treatment, post-treatment, and 6 months after treatment (all completed). Method of measurement: Melbourne Assessment.;Bimanual hand function. Timepoint: Pre-treatment, post-treatment, and 6 months after treatment (all completed). Method of measurement: Assisting Hand Assessment.

Secondary

MeasureTime frame
Arm-hand, real-time function. Timepoint: Pre-treatment, Post-treatment, and 6 months post-treatment (all completed). Method of measurement: Pediatric Motor Activity Log.

Countries

Saudi Arabia

Contacts

Public ContactRagab Kamal Elnaggar

Prince Sattam bin Abdulaziz University

rke_pt2001@yahoo.com+966 11 588 6321

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026